| Literature DB >> 34007534 |
W Kyle Cornell1, Kevin A Clauson2, Jeff Cain1.
Abstract
OBJECTIVES: To advocate for independent pharmacy to embrace digital health as a means to improve patient outcomes and compete more strongly in an increasingly competitive business environment.Entities:
Keywords: Digital health; clinical services; community pharmacy; independent pharmacy; practice model; technology
Year: 2019 PMID: 34007534 PMCID: PMC7643706 DOI: 10.24926/iip.v10i1.1645
Source DB: PubMed Journal: Innov Pharm ISSN: 2155-0417
Condition-specific outcomes with digital health interventions[11]
| Condition | Outcomes |
|---|---|
| Asthma | • Improvements in cough and nighttime symptoms |
| Cardiac Rehabilitation | • Improved exercise capacity as shown by increased distance during a 6-minute walk test (6 MWT) |
| Congestive Heart Failure | • Fewer symptom complaints |
| Chronic Lung Diseases | • Improved cough symptoms and sleep quality |
| Diabetes | • Improved HbA1c, low-density lipoprotein (LDL) cholesterol, and microalbuminuria |
| HIV Management | • Reduced viral load |
| Hypertension | • Mixed results regarding improvement in blood pressure |
| Overweight and Obese Adults (BMI: 25–39.9) | • Short-term weight loss |
| Smoking Cessation | • Increased abstinence rates at 26 weeks |
Barriers to digital health and recommendations for pharmacists
| Barrier | Recommendation |
|---|---|
| A lack of knowledge and reliable information regarding digital health options causing patients to feel overwhelmed, coupled the potential for device fatigue.[ | The pharmacist must embrace a new role as the knowledgeable source on digital health tools, and therefore must self-educate or receive adequate education on this topic. |
| Capabilities of current devices limiting what types of data can be accurately obtained. | Pharmacies must incorporate digital health tools into services that align with the capabilities of current technology (e.g. management of conditions referenced in |
| Challenges in receiving reimbursement from payer such as CMS for clinical services provided by pharmacists. | Pharmacists must continue advocacy efforts focusing on legislation that recognizes the profession with provider status, or creates programs that provide reimbursement for specific services, such as the Diabetes Prevention Program (DPP). |
| A lack of awareness and evidence-based guidelines for the use of digital health tools preventing buy-in from other providers.[ | Pharmacies implementing digital health tools into their practice must provide evidence of positive outcomes to demonstrate their effectiveness. |